Isla Pharmaceuticals Overview
- Founded
- 2017
- Status
- Private
- Latest Deal Type
- Series C
- Latest Deal Amount
- $563K
- Investors
- 2
Isla Pharmaceuticals General Information
Description
Owner and operator of a biotechnology company intended to develop tropical disease therapies. The company's range of offerings includes the development of treatment of dengue infection and other mosquito-borne illnesses, enabling physicians to treat diseases like malaria easily.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 100 Calle del Muelle, 21007
- San Juan, PR 00901
- United States
+1 (510) 000-0000
Isla Pharmaceuticals Timeline
Isla Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series C) | 18-Mar-2020 | $563K | 00.000 | 00.00 | Completed | Generating Revenue |
| 2. Early Stage VC (Series B) | 00000 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 30-Apr-2018 | $1.12M | $1.12M | 00.000 | Completed | Generating Revenue |
Isla Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 00.00 | 0.000 | |
| Series B | 00,000 | 00.000000 | 00 | 00 | 00 | 00 | 0.000 | |
| Series A | 125,000 | $0.000100 | $9 | $9 | 1x | $2.25 | 13.44% |
Isla Pharmaceuticals Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| David Foster Ph.D | President & Board Member |
Isla Pharmaceuticals Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Albert Hansen | KESA Partners | Board Member | 000 0000 |
| David Foster Ph.D | Isla Pharmaceuticals | President & Board Member | 000 0000 |
| Paul MacLeman | Self | Board Member | 000 0000 |
| William Garner MD | Self | Chairman | 000 0000 |
Isla Pharmaceuticals Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| EGB Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| KESA Partners | Merchant Banking Firm | Minority | 000 0000 | 000000 0 |